Article
Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A.
Proceedings of the National Academy of Sciences of the United States of America - 18 Dec 2012
Mazor Ronit, Vassall Aaron N, Eberle Jaime A, Beers Richard, Weldon John E, Venzon David J, Tsang Kwong Y, Benhar Itai, Pastan Ira
Abstract excerpt
Recombinant immunotoxins (RITs) are chimeric proteins that are being developed for cancer treatment. We have produced RITs that contain PE38, a portion of the bacterial protein Pseudomonas exotoxin A. Because the toxin is bacterial, it often induces neutralizing antibodies, which limit the number of treatment cycles and the effectiveness of the therapy. Because T cells are essential for antibody responses to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
